Evidence map›Paper›PMID 26068560›Full record

ArticleMalaria journal2015

Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda.

Carlos J Chaccour, N Regina Rabinovich, Hannah Slater, Sara E Canavati, Teun Bousema, Marcus Lacerda, Feiko Ter Kuile, Chris Drakeley, Quique Bassat, Brian D Foy and 1 more

Open access · goldAbstract readConference Proceedings
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Ivermectin treatment in humans for reducing malaria transmission.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Broadening the range of use cases for ivermectin - a review of the evidence.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Repurposing Drugs to Fight Hepatic Malaria Parasites.Molecules (Basel, Switzerland) · 2020
    Review
  13. Article
  14. A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool.The American journal of tropical medicine and hygiene · 2020
    Article
  15. Article
  16. The effect of ivermectinMalaria journal · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 7 countries.

Carlos J ChaccourDepartment of Internal Medicine, Clinica Universidad de Navarra, Pamplona, Spain. carlos.chaccour@isglobal.org.
N Regina RabinovichISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain. regina.rabinovich@isglobal.org.
Hannah SlaterDepartment of Infectious Disease Epidemiology, MRC Centre for Outbreak Analysis and Modelling, Imperial College London, London, UK. hannah.slater08@imperial.ac.uk.
Sara E CanavatiDepartment of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. saracanavati@yahoo.com.
Teun BousemaRadboud University Medical Center, Nijmegen, The Netherlands. teun.bousema@radboudumc.nl.
Marcus LacerdaFundação de Medicina Tropical Dr. Heitor Vieira Dourado/FIOCRUZ, Manaus, Brazil. marcuslacerda.br@gmail.com.
Feiko Ter KuileLiverpool School of Tropical Medicine, Liverpool, UK. feiko.terkuile@lstmed.ac.uk.
Chris DrakeleyMalaria Centre, London School of Tropical Medicine and Hygiene, London, UK. Chris.Drakeley@lshtm.ac.uk.
Quique BassatISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain. quique.bassat@isglobal.org.
Brian D FoyDepartment of Microbiology, Arthropod-borne and Infectious Diseases Laboratory, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA. Brian.Foy@ColoState.EDU.
Kevin KobylinskiDepartment of Entomology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand. Kevin.Kobylinski.gst@afrims.org.
Armed Forces Research Institute of Medical Science · THBarcelona Institute for Global Health · ESClinica Universidad de Navarra · ESColorado State University · USFundação de Medicina Tropical · BRImperial College London · GBLiverpool School of Tropical Medicine · GBMahidol Oxford Tropical Medicine Research Unit · THManhiça Health Research Centre · MZRadboud University Medical Center · NL

Funding

Ivermectin for Malaria ControlR01AI094349 · NIAID · COLORADO STATE UNIVERSITY · PI FOY, BRIAN DAVID · 2012 to 2015
$2.0M
NIAID NIH HHS R01 AI094349
6 · The paper itself

Abstract

The potential use of ivermectin as an additional vector control tool is receiving increased attention from the malaria elimination community, driven by the increased importance of outdoor/residual malaria transmission and the threat of insecticide resistance where vector tools have been scaled-up. This report summarizes the emerging evidence presented at a side meeting on "Ivermectin for malaria elimination: current status and future directions" at the annual meeting of the American Society of Tropical Medicine and Hygiene in New Orleans on November 4, 2014. One outcome was the creation of the "Ivermectin Research for Malaria Elimination Network" whose main goal is to establish a common research agenda to generate the evidence base on whether ivermectin-based strategies should be added to the emerging arsenal to interrupt malaria transmission.

Indexed as

AnophelesInsecticidesInsect VectorsIvermectinMosquito ControlAnimalsInsecticide ResistanceMalariaNew OrleansInsecticidesIvermectin

Identifiers

PMID26068560
PMCPMC4475618
OpenAlexW1498238503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.